Literature DB >> 12714611

Analysis of the frequent R1141X mutation in the ABCC6 gene in pseudoxanthoma elasticum.

Xiaofeng Hu1, Ron Peek, Astrid Plomp, Jacoline ten ten Brink, George Scheffer, Simone van Soest, Anita Leys, Paulus T V M de Jong, Arthur A B Bergen.   

Abstract

PURPOSE: To characterize the ABCC6 R1141X nonsense mutation, which is implicated in more than 25% of a cohort of patients from The Netherlands with pseudoxanthoma elasticum (PXE).
METHODS: A combination of single-strand conformational polymorphism (SSCP), PCR, sequencing, and Southern blot analysis was used to identify mutations in the ABCC6 gene in 62 patients. Haplotypes of 16 patients with the R1141X mutation were determined with eight polymorphic markers spanning the ABCC6 locus. The effect of the R1141X mutation on the expression of ABCC6 was studied in leukocytes and cultured dermal fibroblasts from affected skin in patients heterozygous or homozygous for the R1141X mutation. ABCC6 expression was analyzed by RT-PCR and immunocytochemistry with ABCC6-specific monoclonal antibodies.
RESULTS: The ABCC6 R1141X mutation was found on 19 alleles in 16 patients with PXE and occurred in heterozygous, homozygous, or compound heterozygous form. All R1141X alleles were associated with a common haplotype, covering at least three intragenic ABCC6 markers. None of the patients or healthy control subjects had a similar ABCC6 haplotype. Furthermore, the results showed that the expression of the normal allele in R1141X heterozygotes was predominant, whereas no detectable, or very low, ABCC6 mRNA levels were found in R1141X homozygotes. Immunocytochemical staining of cultured dermal fibroblasts with ABCC6-specific monoclonal antibodies showed no evidence of the presence of a truncated protein in patients with PXE who were homozygous for R1141X.
CONCLUSIONS: A specific founder effect for the R1141X mutation exists in Dutch patients with PXE. The R1141X mutation induces instability of the aberrant mRNA. Functional haploinsufficiency or loss of function of ABCC6 caused by mechanisms, such as nonsense-mediated decay (NMD), may be involved in the PXE phenotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12714611     DOI: 10.1167/iovs.02-0981

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

Review 1.  ABCC6 and pseudoxanthoma elasticum.

Authors:  Arthur A B Bergen; Astrid S Plomp; Xiaofeng Hu; Paulus T V M de Jong; Theo G M F Gorgels
Journal:  Pflugers Arch       Date:  2006-04-08       Impact factor: 3.657

2.  Development of a rapid, reliable genetic test for pseudoxanthoma elasticum.

Authors:  Yanggu Shi; Sharon F Terry; Patrick F Terry; Lionel G Bercovitch; Gary F Gerard
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

Review 3.  Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations.

Authors:  N Chassaing; L Martin; P Calvas; M Le Bert; A Hovnanian
Journal:  J Med Genet       Date:  2005-05-13       Impact factor: 6.318

4.  Dietary magnesium, not calcium, prevents vascular calcification in a mouse model for pseudoxanthoma elasticum.

Authors:  Theo G M F Gorgels; Jan H Waarsing; Anneke de Wolf; Jacoline B ten Brink; Willem J P Loves; Arthur A B Bergen
Journal:  J Mol Med (Berl)       Date:  2010-02-23       Impact factor: 4.599

5.  Nonsense mutations in the rhodopsin gene that give rise to mild phenotypes trigger mRNA degradation in human cells by nonsense-mediated decay.

Authors:  Ramon Roman-Sanchez; Theodore G Wensel; John H Wilson
Journal:  Exp Eye Res       Date:  2015-09-26       Impact factor: 3.467

Review 6.  ABCC6, Pyrophosphate and Ectopic Calcification: Therapeutic Solutions.

Authors:  Briana K Shimada; Viola Pomozi; Janna Zoll; Sheree Kuo; Ludovic Martin; Olivier Le Saux
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

7.  Vitamin K supplementation increases vitamin K tissue levels but fails to counteract ectopic calcification in a mouse model for pseudoxanthoma elasticum.

Authors:  Theo G M F Gorgels; Jan H Waarsing; Marjolein Herfs; Daniëlle Versteeg; Frank Schoensiegel; Toshiro Sato; Reinier O Schlingemann; Boris Ivandic; Cees Vermeer; Leon J Schurgers; Arthur A B Bergen
Journal:  J Mol Med (Berl)       Date:  2011-07-02       Impact factor: 4.599

8.  Large-scaled metabolic profiling of human dermal fibroblasts derived from pseudoxanthoma elasticum patients and healthy controls.

Authors:  Patricia Kuzaj; Joachim Kuhn; Ryan D Michalek; Edward D Karoly; Isabel Faust; Mareike Dabisch-Ruthe; Cornelius Knabbe; Doris Hendig
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

9.  ABCC6 Mutation in Patients with Angioid Streaks.

Authors:  Yoshihiro Mizutani; Tomohiro Nakayama; Satoshi Asai; Hiroyuki Shimada; Mitsuko Yuzawa
Journal:  Int J Biomed Sci       Date:  2006-02

10.  ABCC6 mutations in pseudoxanthoma elasticum: an update including eight novel ones.

Authors:  Astrid S Plomp; Ralph J Florijn; Jacoline Ten Brink; Bruce Castle; Helen Kingston; Ana Martín-Santiago; Theo G M F Gorgels; Paulus T V M de Jong; Arthur A B Bergen
Journal:  Mol Vis       Date:  2008-01-24       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.